Canton Strategic Holdings (CNTN) Share-based Compensation (2021 - 2026)

Canton Strategic Holdings (CNTN) reported Share-based Compensation of $32.3 million for Q1 2026, up 14618.45% on a YoY basis from N/an in Q1 2025, and up 2586.64% quarter-over-quarter from -$1.3 million in Q4 2025.

Canton Strategic Holdings (CNTN) Share-based Compensation (2021 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Share-based Compensation for 6 years, with the latest figure at $32.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 14618.45% year-over-year to $32.3 million; the trailing twelve-month figure through Mar 2026 stood at $31.7 million (up 3989.6% YoY), and the FY2025 full-year result was $8253.0, down 98.84% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $32.3 million, up from -$1.3 million in the prior quarter.
  • The five-year high for Share-based Compensation was $32.3 million in Q1 2026, with the low at -$1.3 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $2.0 million across 5 years, with a median of $200000.0 in 2025.
  • Annual changes were most pronounced in 2022 — Share-based Compensation slumped 7496.83% — and 2026, when it surged 14618.45%.
  • Canton Strategic Holdings' Share-based Compensation stood at -$498694.0 in 2022, then soared by 216.68% to $581862.0 in 2023, then plunged by 63.72% to $211104.0 in 2024, then plunged by 714.54% to -$1.3 million in 2025, then jumped by 2586.64% to $32.3 million in 2026.
  • The last three Share-based Compensation figures came in at $32.3 million (Q1 2026), -$1.3 million (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - 32.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.26 Mn
Mar 31, 2026 32.26 Mn
Dec 31, 2025 -1.30 Mn
Dec 31, 2025 -1.30 Mn
Sep 30, 2025 200,000.00
Sep 30, 2025 200,000.00
Jun 30, 2025 567,636.00
Jun 30, 2025 567,636.00
Mar 31, 2025 219,179.00
Mar 31, 2025 219,179.00
Dec 31, 2024 211,104.00
Dec 31, 2024 211,104.00
Sep 30, 2024 191,943.00
Sep 30, 2024 191,943.00
Jun 30, 2024 153,647.00
Jun 30, 2024 153,647.00
Mar 31, 2024 153,619.00
Mar 31, 2024 153,619.00
Dec 31, 2023 581,862.00
Dec 31, 2023 581,862.00